Retension Pharmaceuticals, Inc.

Retension Pharmaceuticals, Inc. financial statements

Retension Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 6.3MEODHD
Cash and equivalentsUSD 18.9MEODHD

Retension Pharmaceuticals, Inc. financials on 6ix · Retension Pharmaceuticals, Inc. on 6ix